Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Infectious Diseases
Sex
Male or Female
Age
0+ years
Healthy participants
No

Eligibility criteria

Study overview

The purpose of this study is to learn about the safety and how effective is Zavicefta under actual clinical practice in Japan.

Zavicefta is a combination of Avibactam sodium and Ceftazidime hydrate.

This study is seeking for patients with:

  • sepsis (A very serious infection in your blood caused by germ (a bacteria)) or
  • renal impairment (loss of kidney function) who are administrated with Zavicefta for the first time.


Subjects will take part in this study from the start date of receiving Zavicefta (Day 1) to Day 28.

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    0 site found
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location